Susquehanna International Group
PACB icon

Susquehanna International Group’s Pacific Biosciences PACB Stock Holding History

Susquehanna International Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Buy
160,800
+34,700
+28% +$62.1K ﹤0.01% 11572
2025
Q4 		$236K Buy
126,100
+109,100
+642% +$210K ﹤0.01% 10506
2025
Q3 		$21.8K Sell
17,000
-4,700
-22% -$6.37K ﹤0.01% 12038
2025
Q2 		$26.9K Sell
21,700
-1,434,400
-99% -$1.66M ﹤0.01% 12270
2025
Q1 		$1.72M Buy
+1,456,100
New +$2.23M ﹤0.01% 5873
2024
Q4 		– Sell
-336,700
Closed -$572K – 12933
2024
Q3 		$572K Buy
336,700
+142,000
+73% +$233K ﹤0.01% 8137
2024
Q2 		$267K Buy
194,700
+61,600
+46% +$124K ﹤0.01% 9717
2024
Q1 		$499K Sell
133,100
-255,300
-66% -$1.49M ﹤0.01% 8517
2023
Q4 		$3.81M Buy
388,400
+105,600
+37% +$864K ﹤0.01% 4176
2023
Q3 		$2.36M Buy
282,800
+31,600
+13% +$361K ﹤0.01% 4820
2023
Q2 		$3.34M Sell
251,200
-765,500
-75% -$9.3M ﹤0.01% 4188
2023
Q1 		$11.8M Buy
1,016,700
+802,300
+374% +$7.98M ﹤0.01% 2252
2022
Q4 		$1.75M Sell
214,400
-237,000
-53% -$2.04M ﹤0.01% 4961
2022
Q3 		$2.62M Buy
451,400
+22,200
+5% +$127K ﹤0.01% 4358
2022
Q2 		$1.9M Buy
429,200
+241,600
+129% +$1.47M ﹤0.01% 5018
2022
Q1 		$1.71M Buy
187,600
+90,900
+94% +$1.05M ﹤0.01% 5830
2021
Q4 		$1.98M Sell
96,700
-10,300
-10% -$249K ﹤0.01% 5534
2021
Q3 		$2.73M Sell
107,000
-25,300
-19% -$750K ﹤0.01% 5151
2021
Q2 		$4.63M Sell
132,300
-220,800
-63% -$6.42M ﹤0.01% 4171
2021
Q1 		$11.8M Buy
353,100
+80,900
+30% +$2.83M ﹤0.01% 2528
2020
Q4 		$7.06M Buy
272,200
+133,400
+96% +$2.27M ﹤0.01% 2927
2020
Q3 		$1.37M Buy
138,800
+49,500
+55% +$285K ﹤0.01% 5373
2020
Q2 		$308K Buy
89,300
+21,600
+32% +$73.5K ﹤0.01% 8320
2020
Q1 		$207K Buy
67,700
+18,700
+38% +$76.6K ﹤0.01% 8622
2019
Q4 		$252K Buy
+49,000
New +$249K ﹤0.01% 8347
2019
Q3 		– Sell
-76,600
Closed -$463K – 10644
2019
Q2 		$463K Buy
76,600
+40,400
+112% +$283K ﹤0.01% 7419
2019
Q1 		$262K Sell
36,200
-10,600
-23% -$76.7K ﹤0.01% 7450
2018
Q4 		$346K Buy
+46,800
New +$297K ﹤0.01% 6739
2018
Q3 		– Sell
-22,000
Closed -$78K – 9962
2018
Q2 		$78K Buy
22,000
+3,400
+18% +$9.43K ﹤0.01% 9144
2018
Q1 		$38K Buy
+18,600
New +$48.3K ﹤0.01% 9030
2017
Q2 		– Sell
-24,400
Closed -$126K – 9640
2017
Q1 		$126K Sell
24,400
-3,000
-11% -$14.7K ﹤0.01% 8288
2016
Q4 		$104K Sell
27,400
-113,300
-81% -$823K ﹤0.01% 9067
2016
Q3 		$1.26M Buy
140,700
+8,600
+7% +$71.9K ﹤0.01% 4364
2016
Q2 		$929K Sell
132,100
-66,600
-34% -$608K ﹤0.01% 5008
2016
Q1 		$1.69M Sell
198,700
-20,100
-9% -$198K ﹤0.01% 4092
2015
Q4 		$2.87M Buy
218,800
+201,100
+1,136% +$1.8M ﹤0.01% 3361
2015
Q3 		$65K Sell
17,700
-14,200
-45% -$69.4K ﹤0.01% 9300
2015
Q2 		$184K Buy
31,900
+14,000
+78% +$81K ﹤0.01% 9349
2015
Q1 		$105K Sell
17,900
-24,400
-58% -$168K ﹤0.01% 8948
2014
Q4 		$332K Sell
42,300
-27,500
-39% -$176K ﹤0.01% 7960
2014
Q3 		$343K Buy
69,800
+31,400
+82% +$164K ﹤0.01% 7815
2014
Q2 		$237K Buy
38,400
+20,600
+116% +$103K ﹤0.01% 8780
2014
Q1 		$95K Sell
17,800
-1,500
-8% -$9.48K ﹤0.01% 8578
2013
Q4 		$101K Sell
19,300
-4,800
-20% -$22K ﹤0.01% 8632
2013
Q3 		$133K Buy
+24,100
New +$83.7K ﹤0.01% 7964

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's PACB Position: Q1 2026 in Review

Susquehanna International Group reduced its Pacific Biosciences (PACB) stake by 34% in Q1 2026, selling an estimated $1.6M and leaving 1,719,165 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #5872.

Susquehanna International Group first reported a position in PACB in Q2 2013 and has held it in 48 quarters since. The position peaked at $15.3M in Q4 2020. 230 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Susquehanna International Group held 1,719,165 shares of Pacific Biosciences worth $2.27M as of Q1 2026.
  • Susquehanna International Group sold 892,378 Pacific Biosciences shares in Q1 2026, an estimated $1.6M.
  • Pacific Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5872 holding.
  • Susquehanna International Group first reported a position in Pacific Biosciences in Q2 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's Pacific Biosciences position peaked at $15.3M in Q4 2020.
  • 230 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.